"Telephone, n. An invention of the devil which abrogates some of the advantages of making a disagreeable person keep his distance. "
Ambose Bierce
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120070422 | Method of Treating Ocular Disorders A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically macular pigments, to prevent, treat, or delay the onset of age-related ma... | 03/22/2012 |
| 20120071550 | Synergistic combinations of cartonoids and polyphenols The present invention provides a therapeutic composition comprising one or more polyphenols and one or more carotenoids selected from the group consisting of lutein, lycopene and beta-carotene. The invention also provides methods for inhibiting or reducing the productio... | 03/22/2012 |
| 20120071563 | STABILIZER The present invention relates to a stabilizer comprising starch that comprises at least one ester group corresponding to the formula (I) wherein
| |
| 20120045497 | PESTICIDAL COMBINATIONS Stabilized liquid agrochemical compositions are provided which comprise flowable non-aqueous dispersion concentrates comprising a continuous substantially water-miscible liquid phase, a dispersed water-immiscible liquid phase, and a colloidal solid. In one embodiment, t... | 02/23/2012 |
| 20120046242 | MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY The present invention is directed toward a method of treating a subject for a condition mediated by aberrant Wnt/β-catenin signaling by selecting a subject with a condition mediated by aberrant Wnt/β-catenin signaling and administering to the selected subject a compou... | 02/23/2012 |
| 20120039970 | READY-TO-USE, STABLE SUSPENSION OF PARTIALLY AMORPHOUS CAROTENOID PARTICLES The present invention relates to a ready-to-use stable suspension of partially amorphous carotenoid particles, a process for production thereof and also use thereof as additive to animal feeds, foods and food supplements and also cosmetic and pharmaceutical compositions... | 02/16/2012 |
| 20120039964 | NOVEL FORMULATIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS WITH HIGH BIOAVAILABILITY The present invention relates to formulations of a pharmacological effective fat-soluble active ingredient with a high bioavailability of said fat-soluble active ingredient as well as to their manufacture and use as dietary supplement, food, feed, personal care product ... | 02/16/2012 |
| 20110319790 | PHARMACEUTICAL COMPOSITION AND SYSTEM FOR PERMEABILIZING FETAL MEMBRANES Provided is a pharmaceutical composition for permeabilizing fetal membranes including an active ingredient having a log K in the range of 2 to 4, where K is the octanol/water partition coefficient. The active ingredient may be, for example, bupivacaine, sodium lauryl su... | 12/29/2011 |
| 20110217397 | COMPOSITIONS FOR CONTROLLING INSECTS The present invention comprises compositions, methods and cell lines related to controlling insects. An embodiment of a composition comprises a plant essential oil and targets at least one receptor of insects chosen from tyramine receptor, Or83b olfactory receptor, and ... | 09/08/2011 |
| 20110206638 | COMPOSITIONS AND METHODS FOR REDUCING THE MUTATION RATE OF VIRUSES The disclosure provides compositions and methods for reducing the mutation rate of a virus, such as an RNA virus or a DNA virus, in a cell infected with the virus by, in one aspect, contacting the cell with an effective amount of an iron chelator or an antioxidant. Also... | 08/25/2011 |
| 20110207831 | READY-TO-USE, STABLE EMULSION The present invention relates to a stable emulsion, ready for use, of fat-soluble vitamins or carotenoids, a process for the preparation thereof, and the use thereof as addition to animal feeds, human foods and dietary supplements, and cosmetic and pharmaceutical compos... | 08/25/2011 |
| 20110196383 | Atherosclerotic Plaque Dissolution Composition A method and chemical composition for modifying and dissolving atherosclerotic plaques formed in a patient's blood vessels is provided. A chemical composition comprising one or more of an organic substance, an inorganic substance, and a bioactive substance is administer... | 08/11/2011 |
| 20110165259 | COMPOSITE ORGANIC COMPOUND POWDER FOR MEDICAL USE, METHOD FOR PRODUCING SAME AND SUSPENSION OF SAME [Problem to be Solved] The purpose of present invention is to provide a medicine which has low contamination with a fine-pulverizing medium, is safe and has improved bioavailability. [Solution] A method for producing a composite organic com... | 07/07/2011 |
| 20110158921 | Methods of blocking ultraviolet radiation and promoting skin growth using terpenes and terpenoids The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to rejuvenate the skin and increase the protective layer against irradiation by ultraviolet radiation (UVR). More specifically it provides terpenes and terpenoids... | 06/30/2011 |
| 20110150968 | DISSOLVABLE DIETARY SUPPLEMENT STRIP AND METHODS FOR USING THE SAME A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutri... | 06/23/2011 |
| 20110151009 | USE OF FREE RADICAL SCAVENGERS FOR PROTECTING AND TREATING SKIN AND HAIR DAMAGES CAUSED BY CHEMOTHERAPY The present invention relates to the use of one or more free radical scavengers as prophylactically or therapeutically effective substances and microparticles having an average particle size ranging from 5 to 200 μm for the preparation of a topical pharmaceutical compo... | 06/23/2011 |
| 20110135764 | PEST CONTROL USING NATURAL PEST CONTROL AGENT BLENDS Embodiments of the invention relate to a composition for controlling a target pest, wherein the composition includes at least two active ingredients selected from the group consisting of thymyl acetate, linalyl acetate, amyl butyrate, anise star oil, black seed oil, p-c... | 06/09/2011 |
| 20110117194 | PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER The present invention provides a pharmaceutical formulation containing an angiotensin-II receptor blocker and a release-control material as a pharmacologically active ingredient and a pharmaceutical formulation comprising an immediate-release compartment and an extended... | 05/19/2011 |
| 20110082218 | TREATMENT AND MODULATION OF GENE EXPRESSION AND SKIN AGING Methods and compositions for treating modulating and/or ameliorating non-light-induced, particularly non-UV-induced, skin aging in a human, for reducing the basal MMP-10 expression in unirradiated cells of an organism and/or reducing the basal MMP-1 RNA transcription an... | 04/07/2011 |
| 20110081330 | COMPOSITIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS CONTAINING GUM GHATTI The present invention relates to compositions containing plant gums and one or more fat-soluble active ingredients, wherein the composition comprises less than 40 weight-% oil, based on the total composition in dry matter. These compositions can be used for the enrichme... | 04/07/2011 |
| 20110052511 | NOVEL USE OF ORGANIC COMPOUNDS The present invention is directed to the use of a compound selected from the group consisting of β-carotene, lutein, lycopene and β-cryptoxanthin, and mixtures thereof and combinations thereof with CoQ-10 for maintaining the energy metabolism, the energy flow and/or t... | 03/03/2011 |
| 20110038905 | SKIN ANTI-AGING AGENT FOR EXTERNAL USE It is an object of the present invention to provide a skin anti-aging agent for external use which comprises highly safe protein nanoparticles having high transparency due to the small particle size and high permeability into skin. The present invention provides a skin ... | 02/17/2011 |
| 20110009351 | SCREENING ASSAY TO IDENTIFY CORRECTORS OF PROTEIN TRAFFICKING DEFECTS The present invention relates to a novel assay or screen for identifying compounds with potential therapeutic value for the treatment of protein trafficking diseases such as Cystic Fibrosis (CF) and nephrogenic diabetes insipidus (NDI). The usual approach involves expre... | 01/13/2011 |
| 20110002905 | COMPOSITIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS CONTAINING PROTEIN-POLYSACCHARIDE CONJUGATES The present invention relates to compositions containing one or more proteins, one or more polysaccharides and one or more fat-soluble active ingredients and their use for the enrichment, fortification and/or coloration of food beverages, animal feed and/or cosmetics.... | 01/06/2011 |
| 20100303921 | Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan The present invention relates to pharmaceutical compositions comprising a β (1-3) β (1-4) glucan and a pharmaceutically active agent or a botanical extract. A method to extract and purify cereal β-glucan is also described. The high purity of the cereal β-glucan obta... | 12/02/2010 |
| 20100305214 | Use of a Monoterpene to Increase Tissue Repair The invention relates to the use of a monoterpene to increase biological tissue repair, i.e. tissue regeneration or healing, the cosmetic use of a monoterpene to increase biological tissue repair of skin or a mucosa in an individual and the use of a monoterpene for the ... | 12/02/2010 |
| 20100284944 | OFF-NOTE BLOCKING SENSORY ORGANIC COMPOUNDS Disclosed are Compounds that block off-notes in consumables and methods of blocking off-notes in consumables including off-notes provided by artificial sweeteners including aspartame, Saccharin, acesulfame K (Acesulfame potassium), sucralose and cyclamate; and including... | 11/11/2010 |
| 20100273870 | COMPOSITIONS AND METHODS FOR TREATING DEMODEX INFESTATIONS Compositions containing about 0.6% to about 20% of tea tree oil are described. Some compositions are in the form of solutions, suspensions, spray, lotions, gels, pastes, medicated sticks, balms, cleansers (including shampoos and soaps), creams, or ointments. Also descri... | 10/28/2010 |
| 20100267838 | PULVERULENT CAROTENOID PREPARATION FOR COLOURING DRINKS The present invention relates to pulverulent compositions of at least one carotenoid selected from the group consisting of β-carotene, astaxanthin, canthaxanthin, citranaxanthin, lycopene and lutein, a process for the production of these pulverulent compositions, and t... | 10/21/2010 |
| 20100260733 | NOVEL ANTI AGING AGENTS AND METHODS TO IDENTIFY THEM The present invention discloses novel mechanisms in the aging process and describes novel methods for high-throughput screening to identify, detect, and purify agents to be used for improving mitochondrial function, maintaining the cell cycle-arrested state in senescent... | 10/14/2010 |
| 20100226994 | GRANULE, TABLET AND METHODS FOR PRODUCING THE SAME A granule comprising a carrier composed of porous calcium silicate; a functional substance which is an oily liquid or a low-melting solid and a water-soluble antioxidizing agent, which are adsorbed on the carrier; and a granulating component. The problem to be solved is... | 09/09/2010 |
| 20100221372 | WOLFBERRIES AND SKIN INFLAMMATION The present invention relates in general to the field of inflammation. In particular the present invention relates to the use of natural compounds for the preparation of a product to treat or prevent inflammation. For example an extract of wolfberry was shown to have an... | 09/02/2010 |
| 20100190847 | ORAL COMPOSITION WITH AN ANTIAGEING EFFECT ON THE SKIN A composition which is adapted for oral consumption and which comprises: (i) a PPAR ligand; such as EPA or DHA (ii) an oestrogen receptor binding agent; such as soy isoflavones (iii) an agent that is involved in the post-translational modification of collagen; such as a... | 07/29/2010 |
| 20100173986 | SESQUITERPENES AND DERIVATIVES THEREOF FOR USE AS FEED ADDITIVES The present invention relates to the use of sesquiterpenes and derivatives thereof as components of animal feed or feed additives for the improvement of animal performance as well as to the corresponding animal feed or feed additives containing them.... | 07/08/2010 |
| 20100143508 | Limonene and yucca medical compound for treating human diseases and conditions A medical compound for treating a wide variety of human diseases and conditions comprises a medically effective amount of a yucca extract, an effective delivery-enhancing amount of d-Limonene and an organic solvent as the active components. The inactive components inclu... | 06/10/2010 |
| 20100144534 | Compositions and methods for the control of nematodes and soil borne diseases The instant invention relates to compositions and methods for the control of nematodes and soil borne diseases using compositions comprising high terpene containing oils and one or more surfactants. The invention also relates to methods for increasing the wetted soil vo... | 06/10/2010 |
| 20100113588 | Composition and Methods for the Protection of Hair From Treated Pool Water Compositions for treating hair are disclosed. Methods of making and using compositions for treating hair are also disclosed.... | 05/06/2010 |
| 20100062040 | WATER SOLUBLE DRUGS AND SUPPLEMENTS A method of forming water soluble microparticles is disclosed that includes the steps of providing a water insoluble food supplement, mixing the food supplement in a water miscible polar solvent, heating the mixture to increase the solubility and dissolve the food suppl... | 03/11/2010 |
| 20100056624 | ANIMAL MODEL FOR PERIMENOPAUSE AND MENOPAUSE AND METHODS OF INDUCING OVARIAN FAILURE The present invention relates to an animal model for human perimenopause and menopause. Also provided by the present invention are methods of making the animal model and methods of screening using the model. Also provided are methods of inducing ovarian failure in anima... | 03/04/2010 |
| 20090312287 | MULTI-CAROTENOIDS COMPOSITIONS AND METHODS A stable nutritional supplement composition for oral administration comprising, in one form, about 71% by weight, of a tomato extract containing therein at least 2% to 10% by weight of lycopene, 0.25% to 2% by weight of phytoene, and 0.2% to 2% by weight of phytofluene,... | 12/17/2009 |